Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 439, 659 (9 February 2006) | doi:10.1038/439659b; Published online 8 February 2006
Market watch
This week Wood Mackenzie, an Edinburgh-based research and consulting firm, reviews recent trends in biotechnology stocks.After a flat close to 2005, the Nasdaq biotechnology index moved forward in January, with most of the rise attributable to a flurry of recent clinical trials results and acquisition activity.
To read this story in full you will need to login or make a payment (see right).